Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt.
about
Biology of Cholangiocytes: From Bench to BedsideGABA induces the differentiation of small into large cholangiocytes by activation of Ca(2+) /CaMK I-dependent adenylyl cyclase 8.Regulators of Cholangiocyte Proliferation.Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesisTaurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology.Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases.Functional anatomy of normal bile ducts.Role of sex hormones in the modulation of cholangiocyte function.Involvement of cholangiocyte proliferation in biliary fibrosis.Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor.cAMP-guanine exchange factor protection from bile acid-induced hepatocyte apoptosis involves glycogen synthase kinase regulation of c-Jun NH2-terminal kinaseSuppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat.Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.Control of cholangiocyte adaptive responses by visceral hormones and neuropeptidesHepatic nervous system and neurobiology of the liver.H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway.cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 beta/alpha in rat hepatocytesCholangiocyte proliferation and liver fibrosis.Chronic nicotine exposure stimulates biliary growth and fibrosis in normal ratsFollicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1Recent advances in the morphological and functional heterogeneity of the biliary epitheliumMechanisms of Biliary DamageAdenylyl cyclases in the digestive system.Melatonin regulation of biliary functions.The physiological roles of secretin and its receptor.The β-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice.Mechanisms of Biliary Damage.Pathobiology of biliary epithelia.Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis.The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats.Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.
P2860
Q26738866-E39B61BC-78B0-4BAB-8D20-61D1395F2F24Q30542145-7CB4F22C-BBBE-4F85-A2D0-A842544B392AQ33863341-B9914B42-32D6-4405-BA1F-62D1E642495FQ33866778-F81F579D-2B0C-4CEA-8E82-5E31C68D05DFQ33936280-6E7BF308-AC80-4699-A08B-B2385064D0AAQ34358007-72821FC1-1EF6-4F7C-876B-B4848ECDD1CEQ34755613-DECFB9F7-A5CD-4868-936C-B6579E1372E5Q34779022-63F881B1-DE82-4095-9D2D-62126103BA4DQ34992322-B84C3625-4BD5-45EF-AE8B-2D2B744DE471Q34992326-D3A3039B-94AA-49A0-8D96-EFD5E04CBDB0Q35012302-0830FAC6-25FC-47BB-95A0-5324C17A1C12Q35760713-E72B5CF5-B686-40F4-B25D-AD38D64FA7D3Q35939397-FD494926-42EB-45C6-92AD-F87E5B97F3E2Q36466409-45857071-35EA-4AE9-9682-24ED44B48D83Q37067699-E3B59CC4-23CC-4F28-9C82-333BCB35E769Q37068849-0144B142-67D3-45D5-8D29-A9F11DD7CE8AQ37114526-FF3CC98C-B824-4F52-B2F4-8D10FD916C20Q37162455-094C24F3-386E-4943-B72D-E79655CFAE02Q37175438-6C67ED91-A266-4BB0-B0DF-3BA0D69CF835Q37239371-B13424C2-95AD-45EC-89DC-D268F321CEE7Q37264501-3F40FFC2-1AE5-4C1D-A2E9-ED33C5067016Q37662251-0A73E3D4-BBFF-47E8-BFBA-1B2A1C0B3E6FQ38038172-C6716583-ADED-4CD1-B890-CD9DF6DF68B9Q38187513-1194AD27-9FB0-4DAB-A405-A9AC82EB17ADQ38201723-01BE9A43-B078-4559-9F87-E609F24AC658Q38261684-0BB7FADD-56CC-463B-95D9-BE02EB76DB1DQ38985481-4F1646F1-4A07-49B0-B965-7EECCF75C482Q39281829-0CB56ABC-62E9-4A7A-A7C2-E73C0A41317FQ39440062-9B47F15C-BF12-49A2-9DF8-E0F98597EF78Q41503491-B4F364CD-1BB8-4290-A233-6D065CCFBEE8Q42515925-30CD8D4C-4ACB-4912-9208-F307959C7E1EQ44128178-C1809739-4BBE-4D4E-98BB-AD24BFBCC015
P2860
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Adrenergic receptor agonists p ...... levels and activation of Akt.
@en
Adrenergic receptor agonists p ...... levels and activation of Akt.
@nl
type
label
Adrenergic receptor agonists p ...... levels and activation of Akt.
@en
Adrenergic receptor agonists p ...... levels and activation of Akt.
@nl
prefLabel
Adrenergic receptor agonists p ...... levels and activation of Akt.
@en
Adrenergic receptor agonists p ...... levels and activation of Akt.
@nl
P2093
P2860
P356
P1476
Adrenergic receptor agonists p ...... levels and activation of Akt.
@en
P2093
Antonio Benedetti
Domenico Alvaro
Giammarco Fava
Gianfranco Alpini
Heather Francis
Jo Lynne Phinizy
Julie Venter
Luca Marucci
Marco Marzioni
Maria Grazia Mancino
P2860
P304
P356
10.1152/AJPGI.00306.2005
P577
2005-12-08T00:00:00Z